Oxford Biomedica (OXB)

Sector:

Pharma and Biotech

Index:

FTSE Small Cap

242.00p
   
  • Change Today:
      13.50p
  • 52 Week High: 470.00
  • 52 Week Low: 166.80
  • Currency: UK Pounds
  • Shares Issued: 100.00m
  • Volume: 257,599
  • Market Cap: £242.00m
  • RiskGrade: 125

Oxford Biomedica signs new Covid vaccine deal with AstraZeneca

By Frank Prenesti

Date: Friday 01 Jul 2022

LONDON (ShareCast) - (Sharecast News) - Oxford Biomedica has signed a new three-year deal to make AstraZeneca's Covid-19 vaccine beyond this year when the original agreement expires, the company said on Friday.
The Oxford-based gene and cell therapy group said it expected to record about £30m in revenue from the contract in the current financial year.

Under the new deal, manufacturing of vaccines at Oxford manufacturing facility, Oxbox, will be available to AstraZeneca on an as-needed basis beyond 2022.

Email this article to a friend

or share it with one of these popular networks:


Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

 

OXB Market Data

Currency UK Pounds
Share Price 242.00p
Change Today 13.50p
% Change 5.91 %
52 Week High 470.00
52 Week Low 166.80
Volume 257,599
Shares Issued 100.00m
Market Cap £242.00m
RiskGrade 125

OXB Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
32.41% above the market average32.41% above the market average32.41% above the market average32.41% above the market average32.41% above the market average
84.31% above the sector average84.31% above the sector average84.31% above the sector average84.31% above the sector average84.31% above the sector average
Price Trend
50.63% below the market average50.63% below the market average50.63% below the market average50.63% below the market average50.63% below the market average
28.57% above the sector average28.57% above the sector average28.57% above the sector average28.57% above the sector average28.57% above the sector average
Income Not Available
Growth
6.24% above the market average6.24% above the market average6.24% above the market average6.24% above the market average6.24% above the market average
38.89% above the sector average38.89% above the sector average38.89% above the sector average38.89% above the sector average38.89% above the sector average

What The Brokers Say

Strong Buy 1
Buy 3
Neutral 6
Sell 0
Strong Sell 0
Total 10
buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

OXB Dividends

No dividends found

Trades for 29-Apr-2024

Time Volume / Share Price
11:49 35 @ 242.00p
11:47 2,045 @ 244.30p
11:47 266 @ 244.30p
11:41 1,000 @ 244.30p
11:28 5,000 @ 242.85p

OXB Key Personnel

CFO Stuart Paynter
CEO Frank Mathias

Top of Page